{"id":3560,"date":"2020-11-19T15:20:42","date_gmt":"2020-11-19T15:20:42","guid":{"rendered":"http:\/\/www.enyopharma.com\/fr\/?p=3560"},"modified":"2020-11-19T15:20:42","modified_gmt":"2020-11-19T15:20:42","slug":"vonafexor-accepte-comme-nom-generique-pour-eyp001-par-loms","status":"publish","type":"post","link":"https:\/\/www.enyopharma.com\/fr\/vonafexor-accepte-comme-nom-generique-pour-eyp001-par-loms\/","title":{"rendered":"Vonafexor accept\u00e9 comme nom g\u00e9n\u00e9rique pour EYP001 par l&#8217;OMS"},"content":{"rendered":"<p>Nous sommes heureux d&#8217;annoncer que l&#8217;Organisation Mondiale pour la Sant\u00e9 (OMS) a accept\u00e9 vonafexor comme d\u00e9nomination commune internationale (DCI) pour notre compos\u00e9 lead EYP001, agoniste de FXR.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nous sommes heureux d&#8217;annoncer que l&#8217;Organisation Mondiale pour la Sant\u00e9 (OMS) a accept\u00e9 vonafexor comme d\u00e9nomination commune internationale (DCI) pour notre compos\u00e9 lead EYP001, agoniste de FXR.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/www.enyopharma.com\/fr\/vonafexor-accepte-comme-nom-generique-pour-eyp001-par-loms\/\">Lire la suite&nbsp;&raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-3560","post","type-post","status-publish","format-standard","hentry","category-latest-news-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/www.enyopharma.com\/fr\/category\/latest-news-fr\/\" rel=\"category tag\">Br\u00e8ves<\/a>","rttpg_excerpt":"Nous sommes heureux d&#8217;annoncer que l&#8217;Organisation Mondiale pour la Sant\u00e9 (OMS) a accept\u00e9 vonafexor comme d\u00e9nomination commune internationale (DCI) pour notre compos\u00e9 lead EYP001, agoniste de FXR.Lire la suite&nbsp;&raquo;","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3560"}],"version-history":[{"count":1,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3560\/revisions"}],"predecessor-version":[{"id":3561,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3560\/revisions\/3561"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}